391 related articles for article (PubMed ID: 16253120)
1. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection.
Aranha FC; Ribeiro U; Basse P; Corbett CE; Laurenti MD
Scand J Immunol; 2005 Oct; 62(4):334-41. PubMed ID: 16253120
[TBL] [Abstract][Full Text] [Related]
2. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
Prina E; Lang T; Glaichenhaus N; Antoine JC
J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
[TBL] [Abstract][Full Text] [Related]
3. Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection.
Bihl F; Pecheur J; Bréart B; Poupon G; Cazareth J; Julia V; Glaichenhaus N; Braud VM
J Immunol; 2010 Aug; 185(4):2174-81. PubMed ID: 20624944
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
5. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
Schleicher U; Liese J; Knippertz I; Kurzmann C; Hesse A; Heit A; Fischer JA; Weiss S; Kalinke U; Kunz S; Bogdan C
J Exp Med; 2007 Apr; 204(4):893-906. PubMed ID: 17389237
[TBL] [Abstract][Full Text] [Related]
6. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ
Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cells participate in the early defense against Leishmania major infection in mice.
Laskay T; Röllinghoff M; Solbach W
Eur J Immunol; 1993 Sep; 23(9):2237-41. PubMed ID: 8370404
[TBL] [Abstract][Full Text] [Related]
8. Early infection with Leishmania major restrains pathogenic response to Leishmania amazonensis and parasite growth.
González-Lombana CZ; Santiago HC; Macedo JP; Seixas VA; Russo RC; Tafuri WL; Afonso LC; Vieira LQ
Acta Trop; 2008 Apr; 106(1):27-38. PubMed ID: 18313021
[TBL] [Abstract][Full Text] [Related]
9. Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro.
Vendrame CM; Carvalho MD; Rios FJ; Manuli ER; Petitto-Assis F; Goto H
Scand J Immunol; 2007; 66(2-3):287-96. PubMed ID: 17635806
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
[TBL] [Abstract][Full Text] [Related]
11. Effects of hyperbaric oxygen on Leishmania amazonensis promastigotes and amastigotes.
Arrais-Silva WW; Collhone MC; Ayres DC; de Souza Souto PC; Giorgio S
Parasitol Int; 2005 Mar; 54(1):1-7. PubMed ID: 15710544
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-gamma.
Cillari E; Dieli M; Maltese E; Milano S; Salerno A; Liew FY
J Immunol; 1989 Sep; 143(6):2001-5. PubMed ID: 2506273
[TBL] [Abstract][Full Text] [Related]
13. Leishmania chagasi: cytotoxic effect of infected macrophages on parenchymal liver cells.
Dias Costa J; de Nazareth Meirelles M; Eduardo Pereira Velloso C; Porrozzi R
Exp Parasitol; 2007 Dec; 117(4):390-8. PubMed ID: 17719578
[TBL] [Abstract][Full Text] [Related]
14. Effect of hypoxia on macrophage infection by Leishmania amazonensis.
Colhone MC; Arrais-Silva WW; Picoli C; Giorgio S
J Parasitol; 2004 Jun; 90(3):510-5. PubMed ID: 15270094
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection.
Scott MJ; Hoth JJ; Turina M; Woods DR; Cheadle WG
Cytokine; 2006 Jan; 33(2):79-86. PubMed ID: 16488621
[TBL] [Abstract][Full Text] [Related]
16. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
[TBL] [Abstract][Full Text] [Related]
17. Bovine natural killer cells restrict the replication of Mycobacterium bovis in bovine macrophages and enhance IL-12 release by infected macrophages.
Denis M; Keen DL; Parlane NA; Storset AK; Buddle BM
Tuberculosis (Edinb); 2007 Jan; 87(1):53-62. PubMed ID: 16730232
[TBL] [Abstract][Full Text] [Related]
18. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
Liew FY; Dhaliwal JS
J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
[TBL] [Abstract][Full Text] [Related]
19. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
Liese J; Schleicher U; Bogdan C
Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
[TBL] [Abstract][Full Text] [Related]
20. The influence of ecto-nucleotidases on Leishmania amazonensis infection and immune response in C57B/6 mice.
de Souza MC; de Assis EA; Gomes RS; Marques da Silva Ede A; Melo MN; Fietto JL; Afonso LC
Acta Trop; 2010 Sep; 115(3):262-9. PubMed ID: 20399737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
